Markers of AML such as CD7 (T-cell Leukemia Antigen), CD33, CD206 (mannose receptor C type 1, MRC1), and CD38 (ADP-Ribosyl Cyclase 1) were included in the antibody panel. This evidence concerns the gene MRC1 and acute myeloid leukemia.